| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/17/2003 | CN1461656A Medicinal excipient-potassium alginate and its composition |
| 12/17/2003 | CN1461639A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle |
| 12/17/2003 | CN1131034C Novel pharmaceutical composition |
| 12/16/2003 | US6664397 Administering to subject effective dose of (+)-mefloquine or pharmaceutically acceptable salt thereof substantially free of (-)-enantiomer; reduced side effects |
| 12/16/2003 | US6664367 Cyclic peptides containing modified disulfide bonds coupled with a chelating agent capable of complexing with diagnostic and therapeutically useful metal ions, antineoplastic agents, enzymes, coenzymes or toxins |
| 12/16/2003 | US6664292 Topically applying to the affected area in the nail a lower alcohol and a lower carboxylic acid to treat the bacterial or fungal infection |
| 12/16/2003 | US6664288 Method and composition for the treatment of cancer |
| 12/16/2003 | US6664286 Lower and control elevated intraocular pressure |
| 12/16/2003 | US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/16/2003 | US6664242 Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer |
| 12/16/2003 | US6664239 Using combination of agents directed toward various stages of life cycle; alzheimer's disease |
| 12/16/2003 | US6664233 Combination therapy including 9-nitro-20(S)-camptothecin and bleomycin |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 12/16/2003 | US6664068 Antibodies, antiapoptotic agents |
| 12/16/2003 | US6664048 Combination of selection steps used to detect clones that express interacting molecules from false positive clones. |
| 12/16/2003 | US6664040 Complexing to polypeptides; antiproliferation agent |
| 12/16/2003 | US6663892 Multiple portion tablet |
| 12/16/2003 | US6663891 Erythromyacin antibiotic product, use and formulation thereof |
| 12/16/2003 | US6663890 For therapy of bacterial infection; time-release agents |
| 12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
| 12/16/2003 | US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663865 Tumor necrosis factor antagonists and their use in endometriosis |
| 12/16/2003 | US6663863 Method of inhibiting stenosis and restenosis |
| 12/16/2003 | US6663659 Method and apparatus for the photomodulation of living cells |
| 12/16/2003 | CA2093125C Angiotensin ii antagonists |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003102237A1 Treatment with cytokines |
| 12/11/2003 | WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 12/11/2003 | WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION |
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102153A2 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 12/11/2003 | WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003101988A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | WO2003101956A1 Pharmaceutical combination |
| 12/11/2003 | WO2003101950A2 Methods for enhancing motor performance and/or endurance |
| 12/11/2003 | WO2003101539A1 Self-administered contraceptive injection of oily solution |
| 12/11/2003 | WO2003101492A2 Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain |
| 12/11/2003 | WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR |
| 12/11/2003 | WO2003101490A1 Drug composition containing calcium channel antagonist |
| 12/11/2003 | WO2003101489A1 Medicinal composition for treatment for digestive tract disease |
| 12/11/2003 | WO2003101482A2 Liposome vaccine formulations for fin-fish |
| 12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin |
| 12/11/2003 | WO2003101474A1 Combination chemotherapy with chlorotoxin |
| 12/11/2003 | WO2003101458A1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| 12/11/2003 | WO2003101456A1 Use of compounds that stimulate cgmp |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/11/2003 | WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 12/11/2003 | WO2003101446A1 A herbal molecule as potential anti-leukemic drug |
| 12/11/2003 | WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof |
| 12/11/2003 | WO2003101438A1 Treatment for human papillomavirus |
| 12/11/2003 | WO2003101434A2 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 12/11/2003 | WO2003101428A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 12/11/2003 | WO2003101402A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 12/11/2003 | WO2003101395A2 Formulations for amylin agonist peptides |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101389A2 Relief of aids symptoms |
| 12/11/2003 | WO2003101380A2 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors |
| 12/11/2003 | WO2003101281A2 Method for reducing obstructive hydrocephalus |
| 12/11/2003 | WO2003101224A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity |
| 12/11/2003 | WO2003101199A1 Combination therapy for rna virus infections involving ribavirin and impdh inhibitors |
| 12/11/2003 | WO2003092790A3 Methods for increasing the therapeutic response to electroconvulsive therapy ('ect') |
| 12/11/2003 | WO2003080630A3 Phosphate transport inhibitors |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003057235A3 Modification of feeding behavior |
| 12/11/2003 | WO2003057202A8 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/11/2003 | WO2003053347A3 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections |
| 12/11/2003 | WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037166A3 Devices and methods for the restoration of a spinal disc |
| 12/11/2003 | WO2003034996A3 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 12/11/2003 | WO2003032912A3 Treatment of cns disorders using cns target modulators |
| 12/11/2003 | WO2003026564A3 Pharmaceutical compositions for the treatment of urinary disorders |
| 12/11/2003 | WO2003011226A3 Products and drug delivery vehicles |
| 12/11/2003 | WO2003002142A8 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 12/11/2003 | WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
| 12/11/2003 | WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| 12/11/2003 | WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments |
| 12/11/2003 | WO2002089853A3 Compositions having enhanced pharmacokinetic characteristics |
| 12/11/2003 | WO2002089791A3 Acne treatment with lipooxigenase inhibitors |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002065136A3 Yeast screens for agents affecting protein folding |
| 12/11/2003 | WO2002060383A3 Cancer therapy |
| 12/11/2003 | WO2002048165A8 Antiviral agents for treatment of flaviviridae infections |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |